Skip to Content

Join the 'Collagenase Clostridium Histolyticum' group to help and get support from people like you.

Collagenase Clostridium Histolyticum News

FDA Approves Xiaflex as First Drug Treatment for Peyronie’s Disease

Posted 6 Dec 2013 by

December 6, 2013 – The U.S. Food and Drug Administration today approved a new use for Xiaflex (collagenase clostridium histolyticum) as the first FDA-approved medicine to treat men with bothersome curvature of the penis, a condition known as Peyronie’s disease. Xiaflex is the first FDA-approved non-surgical treatment option for men with this condition, who have a plaque (lump) in the penis that results in a curvature deformity of at least 30 degrees upon erection. Peyronie’s disease is caused by scar tissue that develops under the skin of the penis. This scar tissue causes an abnormal bend during erection and can cause problems such as bothersome symptoms during intercourse. “Today’s approval expands the available treatment options for men experiencing Peyronie’s disease, and enables them, in consultation with their doctor, to choose the most appropriate treatment option,” said Audre ... Read more

Related support groups: Xiaflex, Peyronie's Disease, Collagenase Clostridium Histolyticum

Ask a Question

Further Information

Related Condition Support Groups

Peyronie's Disease, Dupuytren's contracture

Related Drug Support Groups


Collagenase Clostridium Histolyticum Patient Information at